Sai Life Sciences Ltd share price logo

Sai Life Sciences Ltd Share Price

(SAILIFE)

₹760.850.7%

as on 04:01PM, 28 Mar 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Sai Life Sciences Ltd Performance

  • Day's Low

    Day's High

    ₹750.7
    Day's Price Range
    ₹783
  • 52 Week's Low

    52 Week's High

    ₹639.15
    52-Week Price Range
    ₹808.8
1 Month Return+ 7.88 %
3 Month Return+ 1.94 %
1 Year Return-0.5 %
Previous Close₹755.55
Open₹755.55
Volume6.14L
Upper Circuit₹906.65
Lower Circuit₹604.45
Market Cap₹15,856.30Cr

Sai Life Sciences Ltd Fundamentals

P/E Ratio

21.01

PEG Ratio

0.62

Market Cap

₹15,856.30 Cr

P/B Ratio

0

EPS

0

Dividend Yield

0

Sector

Pharmaceuticals

ROE

9.9

Sai Life Sciences Ltd Analyst Rating

based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts offering long term price targets for Sai Life Sciences Ltd. An average target of ₹803.33

Source: S&P Global Market Intelligence

Sai Life Sciences Ltd Share analysis

Sai Life Sciences Ltd price forecast by 3 analysts

Upside of5.58%

High

₹865

Target

₹803.33

Low

₹720

Sai Life Sciences Ltd target price ₹803.33, a slight upside of 5.58% compared to current price of ₹760.85. According to 3 analysts rating.

Source: S&P Global Market Intelligence

Key events for Sai Life Sciences Ltd

  • Sai Life Sciences Target Price Set at Rs 720 - 18 Mar, 2025

    Jefferies highlights Sai Life Sciences as a strong innovator-focused CDMO with a healthy pipeline and predicts a revenue CAGR of 15% and EBITDA CAGR of 29% over FY25-27. The target price is set at Rs 720, reflecting a premium valuation due to superior growth prospects, though current valuations may limit upside potential.
  • Jefferies Initiates Coverage on Sai Life Sciences - 17 Mar, 2025

    Jefferies has initiated coverage on Sai Life Sciences with a Hold rating and a target price of Rs 720, citing high valuations. The stock closed at Rs 703.80, with 4% of equity becoming tradable as the lock-in period ends.
  • Sai Life Sciences Expects Growth in CRO Business - 13 Mar, 2025

    Krishna Kanumuri, MD and CEO of Sai Life Sciences, expressed confidence in the company's contract research organization (CRO) business, anticipating growth as its collaboration with Schrödinger progresses.
  • Sai Life Sciences Aims for Strong Growth Ahead - 27 Feb, 2025

    Sai Life Sciences, led by CEO Krishna Kanumuri, projects a 15-20% CAGR while maintaining margins of 28-30%. The company is well-positioned to capitalize on global supply chain shifts post-pandemic.
  • Bulk Deal Boosts Sai Life Sciences Stake - 21 Feb, 2025

    Small Cap World Fund Inc purchased a 0.5% stake in Sai Life Sciences for Rs 72.27 crore. Despite this, shares fell by 2.8%.
  • Sai Life Sciences Stock Sees Significant Activity - 20 Feb, 2025

    The Small Cap World Fund Inc purchased 10.55 lakh shares of Sai Life Sciences at Rs 684.87 per share. On February 20, the stock closed nearly 8% higher at Rs 726.15.

Insights on Sai Life Sciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 7.64% to 11.72% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SAILIFE stock has moved up by 3.0%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 4.24% to 10.19% in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 35.24% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 51.52% to 41.09% in Dec 2024 quarter

Sai Life Sciences Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹383.63Cr (-)₹439.21Cr (↑14.49%)₹279.72Cr (↓36.31%)₹395.56Cr (↑41.41%)₹439.78Cr (↑11.18%)
Net Income₹39.61Cr (-)₹56.13Cr (↑41.71%)-₹13.50Cr (↓124.05%)₹41.51Cr (↓407.48%)₹53.85Cr (↑29.73%)
Net Profit Margin10.33% (-)12.78% (↑23.72%)-4.83% (↓137.79%)10.49% (↓317.18%)12.24% (↑16.68%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,816.48Cr (-)₹2,105.89Cr (↑15.93%)₹2,185.04Cr (↑3.76%)₹2,291.05Cr (↑4.85%)
Total Liabilities₹948.96Cr (-)₹1,214.86Cr (↑28.02%)₹1,272.31Cr (↑4.73%)₹1,279.85Cr (↑0.59%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹108.75Cr (-)-₹25.94Cr (↓123.85%)₹88.38Cr (↓440.71%)₹221.47Cr (↑150.59%)₹250.64Cr (↑13.17%)

Sai Life Sciences Ltd Index Inclusions

Nifty Smallcap 250

₹15,104.05

-0.05 (-7.6%)

Nifty MidSmallcap 400

₹17,677.95

-0.2 (-36.15%)

BSE IPO

₹13,468.71

-1.07 (-145.95%)

BSE Healthcare

₹41,421.50

-0.12 (-48.19%)

Nifty 500

₹21,339.55

-0.32 (-68.4%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹46,638.13

-0.35 (-165.52%)

Sai Life Sciences Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
35.24%
0.00
Foreign Institutions
11.72%
53.44
Mutual Funds
10.19%
140.58
Retail Investors
41.09%
-20.24
Others
1.76%
28.39

Sai Life Sciences Ltd Key Indicators

Details20202021202220232024
Return On Equity %10.617.860.52.699.9
Details2021202220232024
Return On Assets %3.360.30.463.61

Sai Life Sciences Ltd Valuation

Sai Life Sciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (18.03x)

January 27, 2025

Today (21.01x)

March 28, 2025

Industry (53.18x)

March 28, 2025

Highest (21.54x)

January 3, 2025

LowHigh

Sai Life Sciences Ltd Earnings and Dividends

  • Sai Life Sciences Ltd Earnings Results

    Sai Life Sciences Ltd’s net profit jumped 35.95% since last year same period to ₹53.85Cr in the Q3 2024-2025. On a quarterly growth basis, Sai Life Sciences Ltd has generated 29.73% jump in its net profits since last 3-months.

    Read More about Earnings Results

Sai Life Sciences Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Sai Life Sciences Ltd is currently in a Bullish trading position according to technical analysis indicators.

Sai Life Sciences Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹15,856.30 Cr-0.1%0.73₹82 Cr₹1,465 Cr
NA₹22.46 Cr78.35%0.50NANA
NA₹1,923.52 Cr980.26%0.54₹36 Cr₹295 Cr
NA₹901.74 Cr648.5%0.65₹23 Cr₹307 Cr
NA₹117.60 Cr31.24%0.72-₹10 Cr₹368 Cr

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as Sai Dru Syn Laboratories Limited as a Public Limited Company dated January 25 1999 issued by the Registrar of Companies Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies Andhra Pradesh on February 17 1999. Subsequently the Company name was changed from Sai Dru Syn Laboratories Limited to Sai Life Sciences Limited dated December 16 2003.Thereafter the name of the Company was changed from Sai Life Sciences Limited to Sai Advantium Pharma Limited dated August 30 2006 issued by the Registrar of Companies Andhra Pradesh. Subsequently the Company name was changed from Sai Advantium Pharma Limited to Sai Life Sciences Limited and a fresh Certificate of Incorporation dated May 28 2012 was issued by the Registrar of Companies Andhra Pradesh at Hyderabad.The Company is an innovatorfocused contract research development and manufacturing organization CRDMO. The Company provide endtoend services across the drug discovery development and manufacturing value chain for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both a discovery / contract research and b CMC / CDMO capabilities.Through the Scheme of Amalgamation Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later the Company opened new areas of biology facility in Watertown Greater Boston MA U.S.A. for innovative and creative smallmolecule drugs in 2019. It launched Sai Nxt an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge Massachusetts USA.In 2021 the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022 it opened the first set of new disconvery chemistry labs at Unit III Plant Hyderabad. In 2023 the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has started API developability formulations DF capabilities at Unit II Hyderabad in 2024.The Company is proposing to raise money from public through IPO by issue and allotment of 61573120 Equity Shares through Offer for Sale and a Fresh Issue aggregating to Rs 800 Crores Equity Shares..

Revenue: ₹439.78Cr as on December 2024 (Q4 24)
Net Profit: ₹53.85Cr as on December 2024 (Q4 24)
Listing date: 18 Dec, 2024
Chairperson Name: Ranga Raju Kanumuri
OrganisationSai Life Sciences Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Sai Life Sciences Ltd

What is Sai Life Sciences Ltd price today?

Sai Life Sciences Ltd share price today stands at ₹760.85, Open: ₹755.55, Previous Close: ₹755.55, High: ₹783, Low: ₹750.7, 52 Week High: ₹808.8, 52 Week Low: ₹639.15.

How to Buy Sai Life Sciences Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Sai Life Sciences Ltd shares

What are today's traded volumes of Sai Life Sciences Ltd?

Today's traded volume of Sai Life Sciences Ltd(SAILIFE) is 6.14L.

What is today's market capitalisation of Sai Life Sciences Ltd?

Today's market capitalisation of Sai Life Sciences Ltd(SAILIFE) is ₹15856.3Cr.

What is the 52 Week High and Low Range of Sai Life Sciences Ltd?

Sai Life Sciences Ltd (SAILIFE)
Price
52 Week High
₹808.8
52 Week Low
₹639.15

How much percentage Sai Life Sciences Ltd is down from its 52 Week High?

Sai Life Sciences Ltd (SAILIFE) share price is ₹760.85. It is down -5.93% from its 52 Week High price of ₹808.8

How much percentage Sai Life Sciences Ltd is up from its 52 Week low?

Sai Life Sciences Ltd (SAILIFE) share price is ₹760.85. It is up 19.04% from its 52 Week Low price of ₹639.15